Americans mixed on potential Trump healthcare priorities: KFF poll
About half of respondents said the nation should spend more on Medicaid and Medicare — a potential challenge for the Trump administration looking to cut costs.
Providers to target efficiency, supply chain resilience in 2025
Health systems will seek to expand their supply chains and partnerships in 2025, while trimming excessive AI programs and nonclinical staff.
DOJ sues Walgreens for allegedly filling millions of illegal prescriptions, including opioids
Walgreens countersued the government the same day. Analysts said a settlement is likely.
Trump reverses Biden healthcare directives, withdraws from WHO in first executive orders
The rescinded orders include directives boosting the Affordable Care Act exchanges, coordinating the government’s COVID-19 response and overseeing artificial intelligence tools.
ACA enrollment breaks records again in 2025
About 24.2 million people signed up for Affordable Care Act plans during the open enrollment period for 2025, with huge increases in major Republican-led states.
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
The invisible edge: an introduction to AI-enabled data migration
AI transforms medical data migration: faster, smarter and ready for the future of healthcare.
Welsh Carson agrees to pare back anesthesia market power to avoid new FTC suit
Antitrust regulators have reached a deal with Welsh, Carson, Anderson and Stowe that doesn’t penalize the private equity firm for rolling up the market for anesthesia services in Texas, but tries to prevent it from happening again.
False claims settlements in healthcare total $1.7B in 2024
Healthcare fraud investigations accounted for more than half of the Department of Justice’s settlements and judgments in 2024, which totaled north of $2.9 billion.
Divestitures and distressed deals defined hospital M&A in 2024: report
Last year was a record year for health system divestitures, and Kaufman Hall expects to see more in 2025.